LABCORP HOLDINGS INC.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Adoption or Termination of Trading Arrangements:
During the quarter ended June 30, 2026, none of the Company’s directors or officers informed it of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below:
| Name and Title · Date Adopted · Character of Trading Agreement · Aggregate Number of Shares of Common Stock to be (Sold) Purchased Pursuant to Trading Agreement · Expiration Date | ||||||
|---|---|---|---|---|---|---|
| Jonathan C. Meltzer | May 7, 2026 | Rule 10b5-1 Trading Arrangement | (1,178) | (1) | December 31, 2027 | (2) |
| Executive Vice President, Chief Operations Officer | ||||||
| Kerrii B. Anderson | May 18, 2026 | Rule 10b5-1 Trading Arrangement | (3,000) | August 10, 2027 | (2) | |
| Director | ||||||
(1)The figure presented represents the shares to be sold on the vesting of equity awards and may vary subject to the achievement of certain performance conditions and/or shares to be withheld for tax purposes.
(2)This trading arrangement permits transactions through the completion of all sales on the respective order entry date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.